Iron Deposition on SWI-Filtered Phase in the Subcortical Deep Gray Matter of Patients with Clinically Isolated Syndrome May Precede Structure-Specific Atrophy

BACKGROUND AND PURPOSE: Increasing evidence suggests that iron deposition is present in the later stages of MS. In this study we examined abnormal phase values, indicative of increased iron content on SWI-filtered phase images of the SDGM in CIS patients and HC. We also examined the association of abnormal phase with conventional MR imaging outcomes at first clinical onset. MATERIALS AND METHODS: Forty-two patients with CIS (31 female, 11 male) and 65 age and sex-matched HC (41 female, 24 male) were scanned on a 3T scanner. Mean age was 40.1 (SD = 10.4) years in patients with CIS, and 42.8 (SD = 14) years in HC, while mean disease duration was 1.2 years (SD = 1.3) in patients with CIS. MP-APT, NPTV, and normalized volume measurements were derived for all SDGM structures. Parametric and nonparametric group-wise comparisons were performed, and associations were determined with other MR imaging metrics. RESULTS: Patients with CIS had significantly increased MP-APT (P = .029) and MP-APT volume (P = .045) in the pulvinar nucleus of the thalamus compared with HC. Furthermore, the putamen (P = .004), caudate (P = .035), and total SDGM (P = .048) displayed significant increases in MP-APT volume, while MP-APT was also significantly increased in the putamen (P = .029). No global or regional volumetric MR imaging differences were found between the study groups. Significant correlations were observed between increased MP-APT volumes of total SDGM, caudate, thalamus, hippocampus, and substantia nigra with white matter atrophy and increased T2 lesion volume (P < .05). CONCLUSION: Patients with CIS showed significantly increased content and volume of iron, as determined by abnormal SWI-phase measurement, in the various SDGM structures, suggesting that iron deposition may precede structure-specific atrophy.

[1]  Yu-Chung N. Cheng,et al.  Susceptibility weighted imaging (SWI) , 2004, Zeitschrift fur medizinische Physik.

[2]  R. Grossman,et al.  Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging , 2009, Journal of magnetic resonance imaging : JMRI.

[3]  Robert Zivadinov,et al.  Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis A case-control study , 2012, NeuroImage.

[4]  R. Henry,et al.  Regional grey matter atrophy in clinically isolated syndromes at presentation , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[5]  David H. Miller,et al.  Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial , 2009, The Lancet Neurology.

[6]  C. W. Tjoa,et al.  MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis , 2005, Journal of the Neurological Sciences.

[7]  Marco Bozzali,et al.  Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging. , 2010, Radiology.

[8]  M. Ramanathan,et al.  Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. , 2007, Human molecular genetics.

[9]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[10]  Phil Lee,et al.  Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis , 2011, BMC Neuroscience.

[11]  J. Ranjeva,et al.  Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis - a two-year longitudinal MRI/MRSI study of corpus callosum , 2007, Multiple sclerosis.

[12]  David H. Miller,et al.  Gray matter atrophy is related to long‐term disability in multiple sclerosis , 2008, Annals of neurology.

[13]  H. Fenton,et al.  LXXIII.—Oxidation of tartaric acid in presence of iron , 1894 .

[14]  W Craelius,et al.  Iron deposits surrounding multiple sclerosis plaques. , 1982, Archives of pathology & laboratory medicine.

[15]  Rohit Bakshi,et al.  Iron in chronic brain disorders: Imaging and neurotherapeutic implications , 2007, Neurotherapeutics.

[16]  Robert Zivadinov,et al.  Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis , 2011, Journal of Neurology.

[17]  S Ropele,et al.  Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing–remitting multiple sclerosis , 2009, Multiple sclerosis.

[18]  David H. Miller,et al.  Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.

[19]  M Ramanathan,et al.  Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. , 2009, Brain : a journal of neurology.

[20]  G A Johnson,et al.  MRI of brain iron. , 1986, AJR. American journal of roentgenology.

[21]  Rohit Bakshi,et al.  Gray matter involvement in multiple sclerosis , 2007, Neurology.

[22]  A. Thompson,et al.  Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis , 2005, The Lancet Neurology.

[23]  Ferdinand Schweser,et al.  Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: An approach to in vivo brain iron metabolism? , 2011, NeuroImage.

[24]  S Ropele,et al.  Determinants of brain iron in multiple sclerosis , 2011, Neurology.

[25]  Rohit Bakshi,et al.  Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis , 2010, Multiple sclerosis.

[26]  Roland G. Henry,et al.  Connecting white matter injury and thalamic atrophy in clinically isolated syndromes , 2009, Journal of the Neurological Sciences.

[27]  R Marc Lebel,et al.  Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility‐weighting and T2‐weighting , 2009, Journal of magnetic resonance imaging : JMRI.

[28]  S. Nelson,et al.  Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron , 2008, Annals of neurology.

[29]  Helen Nichol,et al.  Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X‐ray fluorescence , 2010, Journal of magnetic resonance imaging : JMRI.

[30]  R. Rudick,et al.  Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS , 2001, Neurology.

[31]  M. Filippi,et al.  Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis , 2011, Multiple sclerosis.

[32]  E. Haacke,et al.  Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1 , 2008, American Journal of Neuroradiology.

[33]  R. Rudick,et al.  Gray matter atrophy in multiple sclerosis: A longitudinal study , 2008, Annals of neurology.

[34]  M. Calabrese,et al.  The predictive value of gray matter atrophy in clinically isolated syndromes , 2011, Neurology.

[35]  C. Guttmann,et al.  Deep Gray Matter Involvement on Brain MRI Scans Is Associated with Clinical Progression in Multiple Sclerosis , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[36]  Christian Langkammer,et al.  Iron and Neurodegeneration in Multiple Sclerosis , 2011, Multiple sclerosis international.

[37]  R. Bakshi,et al.  Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis , 2006, Multiple sclerosis.

[38]  D. Ramasamy,et al.  Extent of cerebellum, subcortical and cortical atrophy in patients with MS A case-control study , 2009, Journal of the Neurological Sciences.

[39]  J A Helpern,et al.  Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging , 2007, American Journal of Neuroradiology.

[40]  Rohit Bakshi,et al.  Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. , 2005, Archives of neurology.

[41]  R. Bakshi,et al.  Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients , 2001, Journal of the Neurological Sciences.

[42]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[43]  Chiara Romualdi,et al.  Cortical atrophy is relevant in multiple sclerosis at clinical onset , 2007, Journal of Neurology.

[44]  J. Ranjeva,et al.  Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[45]  R Bakshi,et al.  MRI T2 shortening (‘black T2’) in multiple sclerosis: frequency, location, and clinical correlation , 2000, Neuroreport.

[46]  J. Connor,et al.  Iron, the substantia nigra and related neurological disorders. , 2009, Biochimica et biophysica acta.

[47]  E M Haacke,et al.  Iron stores and cerebral veins in MS studied by susceptibility weighted imaging. , 2010, International angiology : a journal of the International Union of Angiology.

[48]  Steven M LeVine,et al.  Iron deposits in multiple sclerosis and Alzheimer's disease brains , 1997, Brain Research.

[49]  P. Matthews,et al.  Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability , 2011, Multiple sclerosis.

[50]  R. Zivadinov,et al.  Iron deposition and inflammation in multiple sclerosis. Which one comes first? , 2011, BMC Neuroscience.

[51]  M. Filippi,et al.  T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis , 2009, Multiple sclerosis.

[52]  Stephen M. Smith,et al.  A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.

[53]  R. Bakshi,et al.  T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. , 2002, Archives of neurology.